Blog > US Stocks and Markets > Hot Stock Confidential takes 41% on Nymox (NYMX) and 28% profits on Synta (SNTA) in under 4 weeks
 | Email This Article Email This Article  | 

Hot Stock Confidential takes 41% on Nymox (NYMX) and 28% profits on Synta (SNTA) in under 4 weeks

Posted August 13, 2008

Four weeks after we launched our premium service Hot Stock Confidential, we closed out Nymox Pharmaceutical Corporation  (NASDAQ:NYMX) and Synta Pharmaceuticals Corp. (NASDAQ:SNTA) at 41% and 28% gains, respectively. Even better, our contrarian oil play is really taking off!

by J. Christoph Amberger

Baltimore — (TFN): “Sell SNTA at the current price of $7.92 for 26.52% gains!” And “Sell NYMX at the current price of $5.56 for 41.84% gains!” Our laconic notification of our Hot Stock Confidential subscribers marked the first gains taken in our brand-new premium product.

The two baby pharma stocks had experienced their first round of event-driven gains and were ripe for some conservative profit taking. I am happy to say that the gains we marked for our HSC portfolio are coming in at the lower end. We marked prices with the launch dat of our service on July 14… and subscribers joining us afterwards had the opportunity to buy at much lower prices… and get out at slightly higher levels after our sell alerts went out.

We’ll be re-entering these two stocks at a later time… probably right before major trial results. And we’re still holding a full clip of excellent speculative mini pharma positions with equally attractive short-term upside.

Even better, after a delayed start that brought the stock a good 12% below our recommended buy price, the our contrarian oil play has made up lost ground fast and is up almost 20% over the official entry price. And Laura Cadden’s Host Stock Pick of the Week from last Thursday is up almost by the same margin! She called it The Best Energy Stock to Buy Now — and is apparently right on the money.

Now seriously… can you afford not to be on our subscriber list? Find out more about our DGS Investing Strategy and our current HSC watchlist right here…


Related Articles


Posted by J. Christoph Amberger · Filed Under US Stocks and Markets 

Comments

close Reblog this comment
Powered by Disqus · Learn more
blog comments powered by Disqus